Literature DB >> 8856680

A novel antioxidant alleviates heat hyperalgesia in rats with an experimental painful peripheral neuropathy.

M Tal1.   

Abstract

Rats with an experimental painful peripheral neuropathy (the chronic injury (CCI) model) display heatevoked hyperalgesia. There is now considerable evidence that nitric oxide (NO) and nitric oxide synthase are involved in the development of hyperalgesia in acute inflammatory pain states. The mechanisms responsible for hyperalgesia in chronic pain state may involve not only NO itself, but also peroxynitrite, the product of its reaction with superoxide radical, .O2- that can lead to the formation of the free radicals .OH and NO2- Under normal metabolic conditions, the cellular enzyme super oxide dismutase (SOD) provides physiological defence against superoxide radicals. TEMPOL mimics SOD and acts as a catalyst to remove the .O2- radical. The present work shows the efficacy of a stable nitroxide radical, 4-hydroxy-2, 2, 6, 6-tetramethylpiperidine-1-oxyl (TEMPOL), against heat-evoked hyperalgesia.

Entities:  

Mesh:

Substances:

Year:  1996        PMID: 8856680     DOI: 10.1097/00001756-199605310-00010

Source DB:  PubMed          Journal:  Neuroreport        ISSN: 0959-4965            Impact factor:   1.837


  33 in total

Review 1.  Roles of reactive oxygen and nitrogen species in pain.

Authors:  Daniela Salvemini; Joshua W Little; Timothy Doyle; William L Neumann
Journal:  Free Radic Biol Med       Date:  2011-01-28       Impact factor: 7.376

2.  D-Amino acid oxidase-mediated increase in spinal hydrogen peroxide is mainly responsible for formalin-induced tonic pain.

Authors:  Jin-Miao Lu; Nian Gong; Yan-Chao Wang; Yong-Xiang Wang
Journal:  Br J Pharmacol       Date:  2012-03       Impact factor: 8.739

3.  The antioxidant N-(2-mercaptopropionyl)-glycine (tiopronin) attenuates expression of neuropathic allodynia and hyperalgesia.

Authors:  Muhammad Shahid; Fazal Subhan; Nazar Ul Islam; Nisar Ahmad; Umar Farooq; Sudhair Abbas; Shehla Akbar; Ihsan Ullah; Naila Raziq; Zia Ud Din
Journal:  Naunyn Schmiedebergs Arch Pharmacol       Date:  2020-10-20       Impact factor: 3.000

4.  Intrathecal Administration of Tempol Reduces Chronic Constriction Injury-Induced Neuropathic Pain in Rats by Increasing SOD Activity and Inhibiting NGF Expression.

Authors:  Baisong Zhao; Yongying Pan; Zixin Wang; Yonghong Tan; Xingrong Song
Journal:  Cell Mol Neurobiol       Date:  2015-10-03       Impact factor: 5.046

5.  Anti-superoxide and anti-peroxynitrite strategies in pain suppression.

Authors:  Kali Janes; William L Neumann; Daniela Salvemini
Journal:  Biochim Biophys Acta       Date:  2011-12-19

6.  Involvement of reactive oxygen species in long-term potentiation in the spinal cord dorsal horn.

Authors:  Kwan Yeop Lee; Kyungsoon Chung; Jin Mo Chung
Journal:  J Neurophysiol       Date:  2009-11-11       Impact factor: 2.714

7.  Supraspinal inactivation of mitochondrial superoxide dismutase is a source of peroxynitrite in the development of morphine antinociceptive tolerance.

Authors:  T Doyle; L Bryant; I Batinic-Haberle; J Little; S Cuzzocrea; E Masini; I Spasojevic; D Salvemini
Journal:  Neuroscience       Date:  2009-07-14       Impact factor: 3.590

8.  Persistent facial pain increases superoxide anion production in the spinal trigeminal nucleus.

Authors:  Emanuela Viggiano; Marcellino Monda; Alessandro Viggiano; Andrea Viggiano; Caterina Aurilio; Bruno De Luca
Journal:  Mol Cell Biochem       Date:  2010-01-08       Impact factor: 3.396

9.  Lipophilicity is a critical parameter that dominates the efficacy of metalloporphyrins in blocking the development of morphine antinociceptive tolerance through peroxynitrite-mediated pathways.

Authors:  Ines Batinić-Haberle; Michael M Ndengele; Salvatore Cuzzocrea; Júlio S Rebouças; Ivan Spasojević; Daniela Salvemini
Journal:  Free Radic Biol Med       Date:  2008-10-17       Impact factor: 7.376

10.  Reactive oxygen species mediate TNFR1 increase after TRPV1 activation in mouse DRG neurons.

Authors:  Fei Ma; Liping Zhang; Karin N Westlund
Journal:  Mol Pain       Date:  2009-06-17       Impact factor: 3.395

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.